Gastroenterology

In a recent issue of Mayo Clinic's Digestive Diseases, Michael Camilleri, M.D., a gastroenterologist at Mayo Clinic, and Leslie Donato, Ph.D., Co-Director for Cardiovascular Laboratory Medicine, Hospital Clinical Laboratory, and Point of Care Testing at Mayo Clinic, discuss bile acid malabsorption testing in clinical practice.

By Kelley Luedke • March 9, 2018

In this month’s “Hot Topic,” Melissa Snyder, Ph.D., will review the diagnostic testing algorithms for celiac disease and highlight the advantages and limitations of certain tests, including serology and genetic assays.

By MCL Education • March 5, 2018

Leslie Donato, Ph.D., Consultant in Cardiovascular Laboratory Medicine and Clinical Core Laboratory at Mayo Clinic, recently authored an article in "Medical Lab Management" on new laboratory testing options to evaluate irritable bowel syndrome with diarrhea (IBS-D) patients. 

By Kelley Luedke • December 29, 2017

This week’s Research Roundup highlights prehospital transfusion for gastrointestinal bleeding.

By Kelley Luedke • November 20, 2017

This "Specialty Testing" webinar will outline the different tests to detect patients who are at risk for thiopurine-related toxicity and the advantages of each test.

By MCL Education • November 6, 2017

Ann Moyer, M.D., Ph.D., discusses an additional gene, NUDT15, which is important in the prediction of thiopurine-related toxicity This gene has been added to our TPMT genotyping assay available through Mayo Medical Laboratories.

By Mayo Clinic Laboratories • October 25, 2017

This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.

By Kelley Luedke • September 11, 2017

An algorithm is a step-by-step procedure to guide clinicians and laboratorians in appropriate laboratory test ordering.

By Brent Westra • July 28, 2017

Leslie Donato, Ph.D., DABCC, Co-Director of the Cardiovascular Laboratory Medicine and Co-Director of the Hospital Clinical Laboratory and Point-of-Care Testing at Mayo Clinic in Rochester, recently authored an article in Clinical Laboratory News on irritable bowel syndrome.

By Kelley Luedke • May 11, 2017

This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.

By Kelley Luedke • April 17, 2017

Detection of individuals with low thiopurine methyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.

By Mayo Clinic Laboratories • March 29, 2017

Mayo Clinic has completed validation of its existing Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum test for the new biosimilar drug Inflectra. Clients[...]

By Mayo Clinic Laboratories • March 7, 2017

The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. View this "Hot Topic" to learn about testing for IBD and IBS.

By MCL Education • September 6, 2016